Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $75.44 Average Price Target from Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $75.44.

Several equities analysts have recently commented on ACHC shares. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. KeyCorp initiated coverage on Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Royal Bank of Canada lowered their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, December 19th. Finally, Barclays lowered their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd.

Acadia Healthcare Trading Down 0.3 %

NASDAQ ACHC opened at $37.96 on Friday. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The firm has a 50-day moving average price of $41.93 and a 200 day moving average price of $59.68. The stock has a market capitalization of $3.53 billion, a P/E ratio of 12.45, a P/E/G ratio of 1.77 and a beta of 1.29. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.91 earnings per share. Equities research analysts expect that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors have recently made changes to their positions in ACHC. Bank of New York Mellon Corp raised its stake in shares of Acadia Healthcare by 6.6% in the second quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock valued at $84,382,000 after purchasing an additional 77,509 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Acadia Healthcare by 46.0% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,483 shares of the company’s stock valued at $1,856,000 after acquiring an additional 8,657 shares in the last quarter. Principal Financial Group Inc. increased its stake in Acadia Healthcare by 19.4% in the second quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock valued at $43,463,000 after acquiring an additional 104,359 shares during the period. Commonwealth Equity Services LLC lifted its stake in Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after purchasing an additional 257 shares during the period. Finally, nVerses Capital LLC bought a new position in shares of Acadia Healthcare during the 2nd quarter worth approximately $95,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.